LABORATORIOS FARMACEUTICOS ROVI SA
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- -
- Established
- 1946-01-01
- Employees
- 1.4K
- Market Cap
- $4.4B
- Website
- https://www.rovi.es/en/
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
120
CIMA_AEMPS:110
NMPA:9
EMA:1
Drug Approvals
Enoxaparin Sodium Injection
- Product Name
- 依诺肝素钠注射液
- Approval Number
- 国药准字HJ20240045
- Approval Date
- Jun 25, 2024
NMPA
Enoxaparin Sodium Injection
- Product Name
- 依诺肝素钠注射液
- Approval Number
- 国药准字HJ20240048
- Approval Date
- Jun 25, 2024
NMPA
Enoxaparin Sodium Injection
- Product Name
- 依诺肝素钠注射液
- Approval Number
- 国药准字HJ20240047
- Approval Date
- Jun 25, 2024
NMPA
Enoxaparin Sodium Injection
- Product Name
- 依诺肝素钠注射液
- Approval Number
- 国药准字HJ20240044
- Approval Date
- Jun 25, 2024
NMPA
Enoxaparin Sodium Injection
- Product Name
- 依诺肝素钠注射液
- Approval Number
- 国药准字HJ20240046
- Approval Date
- Jun 25, 2024
NMPA
Clinical Trials
No trials found
News
No news found